388 related articles for article (PubMed ID: 12697826)
1. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells.
Mihaylova VT; Bindra RS; Yuan J; Campisi D; Narayanan L; Jensen R; Giordano F; Johnson RS; Rockwell S; Glazer PM
Mol Cell Biol; 2003 May; 23(9):3265-73. PubMed ID: 12697826
[TBL] [Abstract][Full Text] [Related]
2. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer.
Truninger K; Menigatti M; Luz J; Russell A; Haider R; Gebbers JO; Bannwart F; Yurtsever H; Neuweiler J; Riehle HM; Cattaruzza MS; Heinimann K; Schär P; Jiricny J; Marra G
Gastroenterology; 2005 May; 128(5):1160-71. PubMed ID: 15887099
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.
Edwards RA; Witherspoon M; Wang K; Afrasiabi K; Pham T; Birnbaumer L; Lipkin SM
Cancer Res; 2009 Aug; 69(16):6423-9. PubMed ID: 19638594
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo.
Sansom OJ; Bishop SM; Court H; Dudley S; Liskay RM; Clarke AR
DNA Repair (Amst); 2003 Sep; 2(9):1029-39. PubMed ID: 12967659
[TBL] [Abstract][Full Text] [Related]
7. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
[TBL] [Abstract][Full Text] [Related]
8. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
Christmann M; Kaina B
J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
[TBL] [Abstract][Full Text] [Related]
10. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
11. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
[TBL] [Abstract][Full Text] [Related]
12. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair gene expression and genetic instability in testicular germ cell tumor.
Velasco A; Riquelme E; Schultz M; Wistuba II; Villarroel L; Pizarro J; Berlin A; Ittmann M; Koh MS; Leach FS
Cancer Biol Ther; 2004 Oct; 3(10):977-82. PubMed ID: 15467433
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer.
Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J
Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442
[TBL] [Abstract][Full Text] [Related]
15. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
16. Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair.
Tomer G; Buermeyer AB; Nguyen MM; Liskay RM
J Biol Chem; 2002 Jun; 277(24):21801-9. PubMed ID: 11897781
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair and treatment resistance in ovarian cancer.
Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
[TBL] [Abstract][Full Text] [Related]
18. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice.
Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802
[TBL] [Abstract][Full Text] [Related]
19. The immunohistochemical detection of mismatch repair gene proteins (MLH1, MSH2, MSH6, and PMS2): practical aspects in antigen retrieval and biotin blocking protocols.
Manavis J; Gilham P; Davies R; Ruszkiewicz A
Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):73-7. PubMed ID: 12610360
[TBL] [Abstract][Full Text] [Related]
20. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]